Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Carmoterol

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Carmoterol?

Carmoterol is an investigational drug.

There have been 5 clinical trials for Carmoterol. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2006.

The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, and Lung Diseases. The leading clinical trial sponsors are Chiesi Farmaceutici S.p.A., Chiesi Pharmaceuticals Inc., and [disabled in preview].

Recent Clinical Trials for Carmoterol
Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent AsthmaChiesi Farmaceutici S.p.A.Phase 2
Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)Chiesi Pharmaceuticals Inc.Phase 2
Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy VolunteersChiesi Pharmaceuticals Inc.Phase 1

See all Carmoterol clinical trials

Clinical Trial Summary for Carmoterol

Top disease conditions for Carmoterol
Top clinical trial sponsors for Carmoterol

See all Carmoterol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.